Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

23,600 signal articles · 321 in last 24h · 112,439 total before filter · latest 29m ago

321last 24h

2139last 7d

381● bullish (7d)

186● bearish (7d)

204publishers

All Macro299 Earnings1210 M&A91 Regulatory22 Product13 Analyst20

✕ clear all filtersticker: NVOsentiment: bearishSentiment:bullish neutral bearish show all (incl. clickbait)

Investing.com8d agobearish

Novo Nordisk tumbles as Wegovy sales miss, trial setback overshadow raised outlook

Investing.com -- Novo Nordisk (CSE:NOVOb) (NYSE:NVO) hiked its full-year guidance, saying annual sales and operating profit should decline less than previously expected as demand for its weight-loss drugs continues unabated.

NVO